Evidence Hub

Case Report: Pulmonary artery biopsy findings in a patient with a BMPR2 variant-associated pulmonary arterial hypertension

Wu H, Guo L, Wang W, Jiang F, Wang Y

Frontiers in medicine, 2026

Abstract

Mutations in BMPR2 are the most common genetic cause of heritable pulmonary arterial hypertension (PAH). We report a 47-years-old male with a BMPR2 variant (c.246A > G) who presented with dyspnea and recurrent hemoptysis. Right heart catheterization confirmed PAH with a mean PAP of 46 mmHg, PAWP of 3 mmHg, and PVR of 10.75 WU. A pulmonary artery biopsy was performed to exclude alternative diagnoses such as vasculitis and chronic thromboembolism. Histology showed foam cell accumulation in the intima, infiltration of CD3+ T cells, CD20+ B cells, and CD68+ histiocytes in the intima and media, and mucoid deposition. These findings suggest an active inflammatory component and dysregulation of lipid metabolism in early-stage PAH. Targeted PAH therapy improved symptoms, and resolved hemoptysis after bronchial artery embolization. Although the variant is of uncertain significance, this rare biopsy provides early pathological insights into BMPR2-associated PAH. Further studies are needed to clarify mechanisms linking BMPR2, inflammation, and lipid metabolism in vascular remodeling.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free